2014 Annual Meeting | 2HC.016 - Algorithms in the Diagnosis and Treatment of Epilepsy

Date Sunday 04/27/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Fred A. Lado, MD

Topic(s)

Learning Objectives Participants should be able to: manage patients with first seizure by applying risk:benefit analysis using prediction of seizure recurrence based on presentation and ancillary tests; evaluate patients for epilepsy surgery, weighing the advantages/disadvantages of different approaches and understanding the rationale for selecting a specific approach; appropriately refer patients for implementation of and successfully treat them with neurostimulation devices; and recognize who and how to initiate discussion of SUDEP in patients who are at risk.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Tracks Subspecialty in Focus

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:15 PM		Introduction and Overview Fred A. Lado, MD
01:15 PM - 01:50 PM		First Seizure: Diagnosis, Treatment, and Prognosis Sheryl R. Haut, MD
01:50 PM - 02:00 PM		Questions and Answers
02:00 PM - 02:30 PM		Seizure Semiology and Localization Andreas V. Alexopoulos, MD, MPH
02:30 PM - 03:00 PM		Non-invasive and Invasive Methods of Localizing the Seizure Focus Francois Dubeau, MD
03:00 PM - 03:10 PM		Questions and Answers
03:10 PM - 03:25 PM		Break
03:25 PM - 04:00 PM		Treatment of Epilepsy with Implanted Devices: What Are the Indications and Benefits? Barbara C. Jobst, MD, FAAN
04:00 PM - 04:10 PM		Questions and Answers
04:10 PM - 04:45 PM		Discussing SUDEP: If, When, How Jeffrey R. Buchhalter, MD, FAAN
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Fred A. Lado, MD	Dr. Lado has a non-compensated relationship as a Board Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Lado has a non-compensated relationship as a Officer with National Association of Epilepsy Centers that is relevant to AAN interests or activities.
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilog. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford Pharmaceuticals. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.
Barbara C. Jobst, MD, FAAN	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from Harvard Pilgrim. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Francois Dubeau, MD	Dr. Dubeau has nothing to disclose.
Sheryl R. Haut, MD	Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nile AI. Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe.
Andreas V. Alexopoulos, MD, MPH	Dr. Alexopoulos has nothing to disclose.